|
End-of-day quote
Korea S.E.
2026-09-28
|
5-day change | 1st Jan Change | ||
| 7,270.00 KRW | +1.11% |
|
-2.42% | -55.40% |
| 05-18 | TegoScience Inc. agreed to acquire 95.77% stake in PNP Pharm Co., Ltd. for KRW 3.7 billion. | CI |
| 25-05-26 | TegoScience Inc. announced that it has received KRW 27 billion in funding | CI |
Company Valuation: TegoScience Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 245,803 | 174,032 | 97,680 | 117,376 | 100,002 | 130,507 |
| Change | - | -29.2% | -43.87% | 20.16% | -14.8% | 30.5% |
| Enterprise Value (EV) 1 | 222,914 | 153,766 | 76,523 | 98,006 | 74,420 | 95,223 |
| Change | - | -31.02% | -50.23% | 28.07% | -24.07% | 27.95% |
| P/E | 132x | 1,274x | 370x | -50.5x | 29.9x | -18.6x |
| PBR | 4.99x | 3.58x | 2.01x | 2.53x | 2.01x | 2.58x |
| PEG | - | -13.8x | 3.9x | 0x | -0x | 0x |
| Capitalization / Revenue | 28x | 21x | 12.7x | 15.1x | 14.8x | 22x |
| EV / Revenue | 25.4x | 18.5x | 9.97x | 12.6x | 11x | 16x |
| EV / EBITDA | 101x | 313x | 94.4x | -154x | -36x | -24.6x |
| EV / EBIT | 141x | -1,569x | 333x | -82.7x | -28.6x | -21.5x |
| EV / FCF | 246x | 631x | 193x | -39.4x | -56.1x | -24x |
| FCF Yield | 0.41% | 0.16% | 0.52% | -2.53% | -1.78% | -4.17% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 229.9 | 17 | 33 | -290.1 | 418 | -876 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 8,789 | 8,300 | 7,678 | 7,772 | 6,759 | 5,941 |
| EBITDA 1 | 2,210 | 490.7 | 811 | -637.6 | -2,067 | -3,874 |
| EBIT 1 | 1,580 | -98.01 | 229.6 | -1,185 | -2,606 | -4,424 |
| Net income 1 | 1,852 | 139.3 | 264.5 | -2,323 | 3,350 | -7,012 |
| Net Debt 1 | -22,889 | -20,267 | -21,157 | -19,370 | -25,582 | -35,284 |
| Reference price 2 | 30,400.00 | 21,650.00 | 12,200.00 | 14,660.00 | 12,490.00 | 16,300.00 |
| Nbr of stocks (in thousands) | 8,086 | 8,038 | 8,007 | 8,007 | 8,007 | 8,007 |
| Announcement Date | 3/19/21 | 3/23/22 | 3/22/23 | 3/27/24 | 3/19/25 | 3/19/26 |
1KRW in Million2KRW
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 42.41M | |
| -23.72x | 36.06x | -23.41x | -.--% | 79.4B | |
| 17.96x | 4.21x | 9.93x | 0.5% | 78.69B | |
| 20.46x | 4.36x | 13.5x | 2.42% | 59.52B | |
| 21.44x | 4.75x | 13.52x | 0.68% | 46.58B | |
| 33.28x | 11.32x | 21.7x | -.--% | 46.53B | |
| 37.12x | 3.69x | 13.85x | -.--% | 33.63B | |
| 55.29x | 3.51x | 27.23x | -.--% | 25.11B | |
| 63.28x | 7.06x | 42.21x | -.--% | 22.13B | |
| 22.86x | 4.91x | 12.8x | -.--% | 15.31B | |
| Average | 27.55x | 8.88x | 14.59x | 0.4% | 40.69B | |
| Weighted average by Cap. | 18.88x | 11.42x | 8.96x | 0.53% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- A191420 Stock
- Valuation TegoScience Inc.
Select your edition
All financial news and data tailored to specific country editions
